Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SELECTIVE SEROTONIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 354 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Buchsbaum, MS; Hollander, E; Haznedar, MM; Tang, C; Spiegel-Cohen, J; Wei, TC; Solimando, A; Buchsbaum, BR; Robins, D; Bienstock, C; Cartwright, C; Mosovich, S
      Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    2. Condon, JT
      Premenstrual syndrome in primary care: an update

      PRIMARY CARE PSYCHIATRY
    3. Overall, KL
      Pharmacological treatment in behavioural medicine: The importance of neurochemistry, molecular biology and mechanistic hypotheses

      VETERINARY JOURNAL
    4. Sleath, BL; Rubin, RH; Huston, SA
      Antidepressant prescribing to Hispanic and non-Hispanic white patients in primary care

      ANNALS OF PHARMACOTHERAPY
    5. Pollak, PT; Mukherjee, SD; Fraser, AD
      Sertraline-induced hypoglycemia

      ANNALS OF PHARMACOTHERAPY
    6. Deamer, RL; Wilson, DR; Clark, DS; Prichard, JG
      Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM(R))

      JOURNAL OF ADDICTIVE DISEASES
    7. Serebruany, VL; Gurbel, PA; O Connor, CM
      Platelet inhibition by sertraline and N-desmethylsertraline: A possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors

      PHARMACOLOGICAL RESEARCH
    8. Smith, DF; Bender, D; Marthi, K; Cumming, P; Hansen, SB; Peters, D; Nielsen, EO; Scheel-Kruger, J; Gjedde, A
      Synthesis and evaluation of racemic [C-11]NS2456 and its enantiomers as selective serotonin reuptake radiotracers for PET

      NUCLEAR MEDICINE AND BIOLOGY
    9. Kasper, S; Resinger, E
      Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    10. Nelson, MH; Birnbaum, AK; Remmel, RP
      Inhibition of phenytoin hydroxylation in human liver microsomes by severalselective serotonin re-uptake inhibitors

      EPILEPSY RESEARCH
    11. Hervas, I; Vilaro, MT; Romero, L; Scorza, MC; Mengod, G; Artigas, F
      Desensitization of 5-HT1A autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635

      NEUROPSYCHOPHARMACOLOGY
    12. Geller, DA; Hoog, SL; Heiligenstein, JH; Ricardi, RK; Tamura, R; Kluszynski, S; Jacobson, JG
      Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    13. Goulet, M; Miller, GM; Bendor, J; Liu, SH; Meltzer, PC; Madras, BK
      Non-amines, drugs without an amine nitrogen, potently block serotonin transport: Novel antidepressant candidates?

      SYNAPSE
    14. Kirby, D; Ames, D
      Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    15. Biswas, AB; Bhaumik, S; Branford, D
      Treatment-emergent behavioural side effects with selective serotonin re-uptake inhibitors in adults with learning disabilities

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    16. Artigas, F
      Limitations to enhancing the speed of onset of antidepressants - Are rapidaction antidepressants possible?

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    17. Filip, M; Nowak, E; Papla, I; Przegalinski, E
      Role of 5-hydroxytryptamine(1B) receptors and 5-hydroxytryptamine uptake inhibition in the cocaine-evoked discriminative stimulus effects in rats

      JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    18. Nordeng, H; Lindemann, R; Perminov, KV; Reikvam, A
      Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors

      ACTA PAEDIATRICA
    19. Jacobs, ES; Dickstein, DP; Liebelt, EL
      Novel psychotropic medications in children: New toxicities to master

      PEDIATRIC EMERGENCY CARE
    20. Francobandiera, G
      Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: An open study

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    21. Furusho, J; Matsuzaki, K; Ichihashi, I; Satoh, H; Yamaguchi, K; Kumagai, K
      Alleviation of sleep disturbance and repetitive behavior by a selective serotonin re-uptake inhibitor in a boy with Asperger's syndrome

      BRAIN & DEVELOPMENT
    22. Dell'Agnello, G; Ceravolo, R; Nuti, A; Bellini, G; Piccinni, A; D'Avino, C; Dell'Osso, L; Bonuccelli, U
      SSRIs do not worsen Parkinson's disease: Evidence from an open-label, prospective study

      CLINICAL NEUROPHARMACOLOGY
    23. Wieczorek, I; Schulz, C; Jarry, H; Lehnert, H
      The effects of the selective serotonin reuptake-inhibitor fluvoxamine on body weight in Zucker rats are mediated by corticotropin-releasing hormone

      INTERNATIONAL JOURNAL OF OBESITY
    24. McManus, P; Mant, A; Mitchell, P; Birkett, D; Dudley, J
      Co-prescribing of SSRIs and TCAs in Australia: how often does it occur andwho is doing it?

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    25. Shores, MM; Pascualy, M; Lewis, NL; Flatness, D; Veith, RC
      Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects

      PSYCHONEUROENDOCRINOLOGY
    26. Yamada, M; Yamada, M; Yamazaki, S; Takahashi, K; Nara, K; Ozawa, H; Yamada, S; Kiuchi, Y; Oguchi, K; Kamijima, K; Higuchi, T; Momose, K
      Induction of cysteine string protein after chronic antidepressant treatment in rat frontal cortex

      NEUROSCIENCE LETTERS
    27. Brunello, N; Davidson, JRT; Deahl, M; Kessler, RC; Mendlewicz, J; Racagni, G; Shalev, AY; Zohar, J
      Posttraumatic stress disorder: Diagnosis and epidemiology, comorbidity andsocial consequences, biology and treatment

      NEUROPSYCHOBIOLOGY
    28. Ban, TA
      Pharmacotherapy of depression: a historical analysis

      JOURNAL OF NEURAL TRANSMISSION
    29. Blakely, RD
      Physiological genomics of antidepressant targets: Keeping the periphery inmind

      JOURNAL OF NEUROSCIENCE
    30. Montgomery, SA; Kasper, S; Stein, DJ; Hedegaard, KB; Lemming, OM
      Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    31. Ogawa, K; Sasaki, H; Kishi, Y; Yamasaki, H; Okamoto, K; Yamamoto, N; Hanabusa, T; Nakao, T; Nishi, M; Nanjo, K
      A suspected case of proximal diabetic neuropathy predominantly presenting with scapulohumeral muscle weakness and deep aching pain

      DIABETES RESEARCH AND CLINICAL PRACTICE
    32. Pezzella, G; Moslinger-Gehmayr, R; Contu, A
      Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline

      BREAST CANCER RESEARCH AND TREATMENT
    33. Asnis, GM; Hameedi, FA; Goddard, AW; Potkin, SG; Black, D; Jameel, M; Desagani, K; Woods, SW
      Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients

      PSYCHIATRY RESEARCH
    34. Greil, W; Horvath, A; Sassim, N; Erazo, N; Grohmann, R
      Disinhibition of libido: an adverse effect of SSRI?

      JOURNAL OF AFFECTIVE DISORDERS
    35. de la Torre, BR; Dreher, J; Malevany, L; Bagli, M; Kolbinger, M; Omran, H; Luderitz, B; Rao, ML
      Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients

      THERAPEUTIC DRUG MONITORING
    36. Lundmark, J; Reis, M; Bengtsson, F
      Serum concentrations of fluoxetine in the clinical treatment setting

      THERAPEUTIC DRUG MONITORING
    37. Bissette, G
      Effects of sertraline on regional neuropeptide concentrations in olfactorybulbectomized rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    38. Layton, D; Clark, DWJ; Pearce, GL; Shakir, SAW
      Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    39. Eltayb, A; Svensson, TH; Ahlenius, S
      Catalepsy induced by the 5-HT1A receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram

      EUROPEAN JOURNAL OF PHARMACOLOGY
    40. Angulo, J; Peiro, C; Sanchez-Ferrer, CF; Gabancho, S; Cuevas, P; Gupta, S; de Tejada, IS
      Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue

      BRITISH JOURNAL OF PHARMACOLOGY
    41. Pariante, CM; Makoff, A; Lovestone, S; Feroli, S; Heyden, A; Miller, AH; Kerwin, RW
      Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters

      BRITISH JOURNAL OF PHARMACOLOGY
    42. Singh, VP; Jain, NK; Kulkarni, SK
      On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor

      BRAIN RESEARCH
    43. Huber, R; Panksepp, JB; Yue, Z; Delago, A; Moore, P
      Dynamic interactions of behavior and amine neurochemistry in acquisition and maintenance of social rank in crayfish

      BRAIN BEHAVIOR AND EVOLUTION
    44. Odeh, M; Beny, A; Oliven, A
      Severe symptomatic hyponatremia during citalopram therapy

      AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    45. Ramasubbu, R
      Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders

      ACTA PSYCHIATRICA SCANDINAVICA
    46. Stein, DJ; Stein, MB; Goodwin, W; Kumar, R; Hunter, B
      The selective serotonin reuptake in more generalized and in less inhibitorparoxetine is effective generalized social anxiety disorder

      PSYCHOPHARMACOLOGY
    47. Oerther, S; Ahlenius, S
      Involvement of 5-HT1A and 5-HT1B receptors for citalopram-induced hypothermia in the rat

      PSYCHOPHARMACOLOGY
    48. Ruth, U; Mayer-Rosa, J; Schlamp, D; Freisleder, FJ
      Tourette's syndrome and antidepressant therapy: Exacerbation of nervous tics by paroxetine

      ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE
    49. Furusho, J; Kubagawa, T; Saitoh, N; Matsuzaki, K; Yamakawa, H; Iikura, Y
      The first Japanese pediatric case of obsessive-compulsive disorder who responded to a selective serotonin re-uptake inhibitor

      PEDIATRICS INTERNATIONAL
    50. Davidson, JRT
      Social anxiety disorder under scrutiny

      DEPRESSION AND ANXIETY
    51. Hostetter, A; Stowe, ZN; Strader, JR; McLaughlin, E; Llewellyn, A
      Dose of selective serotonin uptake inhibitors across pregnancy: Clinical implications

      DEPRESSION AND ANXIETY
    52. Clark, NA; Alexander, B
      Increased rate of trazodone prescribing with bupropion and selective serotonin-reuptake inhibitors versus tricyclic antidepressants

      ANNALS OF PHARMACOTHERAPY
    53. Parker, NG; Brown, CS
      Citalopram in the treatment of depression

      ANNALS OF PHARMACOTHERAPY
    54. McGettigan, P; Kelly, A; Carvahlo, M; Feely, J
      Anti-depressants in primary care: Analysis of treatment discontinuations

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    55. Millan, MJ; Gobert, A; Rivet, JM; Adhumeau-Auclair, A; Cussac, D; Newman-Tancredi, A; Dekeyne, A; Nicolas, JP; Lejeune, F
      Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha(2)-adrenergic and serotonin(2C) receptors: a comparison with citalopram

      EUROPEAN JOURNAL OF NEUROSCIENCE
    56. Moller, HJ; Grunze, H
      Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants?

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    57. Bosch, TM; van der Werf, TS; Uges, DRA; Ligtenberg, JJM; Fijen, JW; Tulleken, JE; Zijlstra, JG
      Antidepressants self-poisoning and ICU admissions in a University Hospitalin the Netherlands

      PHARMACY WORLD & SCIENCE
    58. Dannon, PN; Sasson, Y; Hirschmann, S; Iancu, I; Grunhaus, LJ; Zohar, J
      Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    59. Frey, R; Schreinzer, D; Stimpfl, T; Vycudilik, W; Berzlanovich, A; Kasper, S
      Suicide by antidepressant intoxication identified at autopsy in Vienna from 1991-1997: the favourable consequences of the increasing use of SSRIs

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    60. Nutt, D
      Treatment of depression and concomitant anxiety

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    61. Tylee, A
      Depression in Europe: experience from the DEPRES II survey

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    62. Liechti, ME; Baumann, C; Gamma, A; Vollenweider, FX
      Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

      NEUROPSYCHOPHARMACOLOGY
    63. Choi, SR; Hou, C; Oya, S; Mu, M; Kung, MP; Siciliano, M; Acton, PD; Kung, HF
      Selective in vitro and in vivo binding of [I-125]ADAM to serotonin transporters in rat brain

      SYNAPSE
    64. Mischoulon, D; Nierenberg, AA; Kizilbash, L; Rosenbaum, JF; Fava, M
      Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: A survey of clinicians

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    65. Todorov, C; Freeston, MH; Borgeat, F
      On the pharmacotherapy of obsessive-compulsive disorder: Is a consensus possible?

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    66. Misri, S; Kostaras, D; Kostaras, X
      The use of selective serotonin reuptake inhibitors during pregnancy and lactation: Current knowledge

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    67. Catalano, MC; Catalano, G; Kanfer, SN; Toner, LC; Stock, SL; Taylor, WD
      The effect of sertraline on routine blood chemistry values

      CLINICAL NEUROPHARMACOLOGY
    68. Reznik, I; Sirota, P
      An open study of fluvoxamine augmentation of neuroleptics in schizophreniawith obsessive and compulsive symptoms

      CLINICAL NEUROPHARMACOLOGY
    69. Catalano, G; Hakala, SM; Catalano, MC
      Sertraline-induced panic attacks

      CLINICAL NEUROPHARMACOLOGY
    70. de Abajo, FJ; Jick, H; Derby, L; Jick, S; Schmitz, S
      Intracranial haemorrhage and use of selective serotonin reuptake inhibitors

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    71. Schlosser, R; Wetzel, H; Dorr, H; Rossbach, W; Hiemke, C; Benkert, O
      Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers

      PSYCHONEUROENDOCRINOLOGY
    72. Brunello, N; Armitage, R; Feinberg, I; Holsboer-Trachsler, E; Leger, D; Linkowski, P; Mendelson, WB; Racagni, G; Saletu, B; Sharpley, AL; Turek, F; Van Cauter, E; Mendlewicz, J
      Depression and sleep disorders: Clinical relevance, economic burden and pharmacological treatment

      NEUROPSYCHOBIOLOGY
    73. Oberndorfer, S; Saletu-Zyhlarz, G; Saletu, B
      Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality

      NEUROPSYCHOBIOLOGY
    74. Nolen, WA; Bleomkolk, D
      Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm

      NEUROPSYCHOBIOLOGY
    75. Van der Linden, G; Van Heerden, B; Warwick, J; Wessels, C; Van Kradenburg, J; Zungu-Dirwayi, N; Stein, DJ
      Functional brain imaging and pharmacotherapy in social phobia: Single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    76. Liechti, ME; Vollenweider, FX
      The serotonin uptake inhibitor citalopram reduces acute cardiovascular andvegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers

      JOURNAL OF PSYCHOPHARMACOLOGY
    77. Millan, MJ; Lejeune, F; Gobert, A
      Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents

      JOURNAL OF PSYCHOPHARMACOLOGY
    78. Hidalgo, RB; Davidson, JRT
      Selective serotonin reuptake inhibitors in post-traumatic stress disorder

      JOURNAL OF PSYCHOPHARMACOLOGY
    79. Hindmarch, I; Kimber, S; Cockle, SM
      Abrupt and brief discontinuation of antidepressant treatment: effects on cognitive function and psychomotor performance

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    80. Markowitz, JS; DeVane, CL; Liston, HL; Montgomery, SA
      An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    81. Meltzer-Brody, S; Conner, KM; Churchill, E; Davidson, JRT
      Symptom-specific effects of fluoxetine in post-traumatic stress disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    82. Stein, DJ; Stahl, S
      Serotonin and anxiety: current models

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    83. Stein, DJ; Seedat, S; van der Linden, GJH; Zungu-Dirwayi, N
      Selective serotonin reuptake inhibitors in the treatment of post-traumaticstress disorder: a metaanalysis of randomized controlled trials

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    84. Davidson, JRT
      Defining an appropriate management strategy for social anxiety disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    85. Baldwin, DS
      Clinical experience with paroxetine in social anxiety disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    86. Nelva, A; Guy, C; Tardy-Poncet, B; Beyens, MN; Ratrema, M; Benedetti, C; Ollagnier, M
      Bleeding syndromes related to selective serotonin reuptake inhibitors (SSRIs). Seven case reports and literature review.

      REVUE DE MEDECINE INTERNE
    87. Buzinkaiova, T; Polonsky, J
      Determination of four selective serotonin reuptake inhibitors by capillaryisotachophoresis

      ELECTROPHORESIS
    88. Hernandez, CR; Smith, GS; Houck, PR; Pollock, BG; Mulsant, B; Dew, MA; Reynolds, CF
      The clinical response to total sleep deprivation and recovery sleep in geriatric depression: potential indicators of antidepressant treatment outcome

      PSYCHIATRY RESEARCH
    89. Kubera, M; Simbirtsev, A; Mathison, R; Maes, M
      Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice

      PSYCHIATRY RESEARCH
    90. Franchini, L; Rossini, D; Bongiorno, F; Spagnolo, C; Smeraldi, E; Zanardi, R
      Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or delay new depressive episodes?

      PSYCHIATRY RESEARCH
    91. Stein, MB; Norton, GR; Walker, JR; Chartier, MJ; Graham, R
      Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study

      PSYCHIATRY RESEARCH
    92. Weller, EB; Weller, RA
      Treatment options in the management of adolescent depression

      JOURNAL OF AFFECTIVE DISORDERS
    93. Lawrenson, RA; Tyrer, F; Newson, RB; Farmer, RDT
      The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared

      JOURNAL OF AFFECTIVE DISORDERS
    94. Lundmark, J; Reis, M; Bengtsson, F
      Therapeutic drug monitoring of sertraline: Variability factors as displayed in a clinical setting

      THERAPEUTIC DRUG MONITORING
    95. Lucca, A; Gentilini, G; Lopez-Silva, S; Soldarini, A
      Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by high-performance liquid chromatography

      THERAPEUTIC DRUG MONITORING
    96. Rasmussen, BB; Brosen, K
      Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?

      THERAPEUTIC DRUG MONITORING
    97. Parsey, RV; Kegeles, LS; Hwang, DR; Simpson, N; Abi-Dargham, A; Mawlawi, O; Slifstein, M; Van Heertum, RL; Mann, JJ; Laruelle, M
      In vivo quantification of brain serotonin transporters in humans using [C-11]McN 5652

      JOURNAL OF NUCLEAR MEDICINE
    98. Sachdev, PS; Brune, M
      Animal models of acute drug-induced akathisia - a review

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    99. Moller, SE; Larsen, F; Pitsiu, M; Rolan, PE
      Effect of citalopram on plasma levels of oral theophylline

      CLINICAL THERAPEUTICS
    100. Sadeg, N; Richecoeur, J; Dumontet, M
      Overdose with venlafaxine associated with benzodiazepines, lithium and alimemazine

      THERAPIE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 19:14:25